FdaApplication
NDA 208042
Identifiers
- fda_app_no: NDA208042
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2018-09-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CASSIPA | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EQ 16MG BASE;EQ 4MG BASE | FILM;SUBLINGUAL |
1 product